Variant report
Variant | esv3481917 |
---|---|
Chromosome Location | chr9:10447007-10451921 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533785373 | chr9:10447016-10447017 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs112523644 | chr9:10447021-10447022 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs570926053 | chr9:10447079-10447080 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs74445718 | chr9:10447085-10447086 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10511546 | chr9:10447115-10447116 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs372826135 | chr9:10447124-10447125 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369245674 | chr9:10447131-10447132 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs141008296 | chr9:10447157-10447158 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs73408148 | chr9:10447177-10447178 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs186065483 | chr9:10447213-10447214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73408151 | chr9:10447249-10447250 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs16926043 | chr9:10447286-10447287 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs78458165 | chr9:10447302-10447303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs532258020 | chr9:10447318-10447319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545449667 | chr9:10447329-10447330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs386732550 | chr9:10447330-10447331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs114445018 | chr9:10447332-10447333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs190482142 | chr9:10447339-10447340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs73408153 | chr9:10447340-10447341 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs527445279 | chr9:10447364-10447365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547590504 | chr9:10447375-10447376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570821368 | chr9:10447380-10447381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs539906135 | chr9:10447385-10447386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs570934719 | chr9:10447386-10447387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs73408154 | chr9:10447402-10447403 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs367564222 | chr9:10447412-10447413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs183053412 | chr9:10447419-10447420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs146581327 | chr9:10447463-10447464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs556053433 | chr9:10447498-10447499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs188665909 | chr9:10447535-10447536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192361512 | chr9:10447572-10447573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Melanoma | 22183965 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:10445200-10447200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
2 | chr9:10445800-10447200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr9:10446000-10447400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr9:10446200-10447400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr9:10446600-10447200 | Flanking Active TSS | iPS-18 Cell Line | embryonic stem cell |
6 | chr9:10446600-10447200 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
7 | chr9:10446600-10447600 | Enhancers | H9 Cell Line | embryonic stem cell |
8 | chr9:10446800-10447200 | Enhancers | H1 Cell Line | embryonic stem cell |
9 | chr9:10447000-10447200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr9:10447000-10447600 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |